Objective： Mangiferin （MF） is a polyphenol isolated from the root of Anemarrhena asphodeloides Bge.. This study wasaimed to investigate the effects of MF on hyperglycemia in animal models of insulin resistance and ...Objective： Mangiferin （MF） is a polyphenol isolated from the root of Anemarrhena asphodeloides Bge.. This study wasaimed to investigate the effects of MF on hyperglycemia in animal models of insulin resistance and streptozotocin（STZ）-induced diabetes. Methods： The diabetes mellitus model was established in mice by receiving a multiplehypodermic injection of hydrocortisone sodium succinate （HCSS） （70 mg/kg） or a single intravenous injection of STZ（130 mg/kg）. Meanwhile MF at different dosage （50, 100 and 200 mg/kg） were oral administrated for consecutive 10days. Data of blood glucose were collected at different time after intraperitoneal injection of insulin （0.5 U/kg） toinvestigate the insulin resistant. As well as the oxygen radical absorbance capacity （ORAC） and superoxide dismutase（SOD） activity of kidney were measured. The in vitro experiment was established to investigate the inhibitory capacity ofMF to α-glucosidase. Results： Oral administration of MF significantly prevented insulin resistance caused by HCSSinjection. STZ-induced diabetic symptoms were also improved, including fasting blood glucose, glycated hemoglobin,plasma triglycerides, hepatic glycogen, kidney SOD and ORAC level. The in vitro experiment demonstrated that MF hadpotent α-glucosidase inhibitory activity. Conclusion： The obtained results demonstrate that MF ameliorates insulinresistance and STZ-induced glucose metabolism disturbance. The MF exerts the protective effects through improving theantioxidant ability, promoting hepatic glycogen synthesis and inhibiting α-glucosidase activity.展开更多
文摘Objective： Mangiferin （MF） is a polyphenol isolated from the root of Anemarrhena asphodeloides Bge.. This study wasaimed to investigate the effects of MF on hyperglycemia in animal models of insulin resistance and streptozotocin（STZ）-induced diabetes. Methods： The diabetes mellitus model was established in mice by receiving a multiplehypodermic injection of hydrocortisone sodium succinate （HCSS） （70 mg/kg） or a single intravenous injection of STZ（130 mg/kg）. Meanwhile MF at different dosage （50, 100 and 200 mg/kg） were oral administrated for consecutive 10days. Data of blood glucose were collected at different time after intraperitoneal injection of insulin （0.5 U/kg） toinvestigate the insulin resistant. As well as the oxygen radical absorbance capacity （ORAC） and superoxide dismutase（SOD） activity of kidney were measured. The in vitro experiment was established to investigate the inhibitory capacity ofMF to α-glucosidase. Results： Oral administration of MF significantly prevented insulin resistance caused by HCSSinjection. STZ-induced diabetic symptoms were also improved, including fasting blood glucose, glycated hemoglobin,plasma triglycerides, hepatic glycogen, kidney SOD and ORAC level. The in vitro experiment demonstrated that MF hadpotent α-glucosidase inhibitory activity. Conclusion： The obtained results demonstrate that MF ameliorates insulinresistance and STZ-induced glucose metabolism disturbance. The MF exerts the protective effects through improving theantioxidant ability, promoting hepatic glycogen synthesis and inhibiting α-glucosidase activity.
